Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
mBio ; : e0131823, 2023 Nov 08.
Article in English | MEDLINE | ID: mdl-37938000

ABSTRACT

Hepatitis C virus (HCV) is the leading cause of death from liver disease. How HCV infection causes lasting liver damage and increases cancer risk remains unclear. Here, we identify bipotent liver stem cells as novel targets for HCV infection, and their erroneous differentiation as the potential cause of impaired liver regeneration and cancer development. We show 3D organoids generated from liver stem cells from actively HCV-infected individuals carry replicating virus and maintain low-grade infection over months. Organoids can be infected with a primary HCV isolate. Virus-inclusive single-cell RNA sequencing uncovered transcriptional reprogramming in HCV+ cells supporting hepatocytic differentiation, cancer stem cell development, and viral replication while stem cell proliferation and interferon signaling are disrupted. Our data add a new pathogenesis mechanism-infection of liver stem cells-to the biology of HCV infection that may explain progressive liver damage and enhanced cancer risk through an altered stem cell state.ImportanceThe hepatitis C virus (HCV) causes liver disease, affecting millions. Even though we have effective antivirals that cure HCV, they cannot stop terminal liver disease. We used an adult stem cell-derived liver organoid system to understand how HCV infection leads to the progression of terminal liver disease. Here, we show that HCV maintains low-grade infections in liver organoids for the first time. HCV infection in liver organoids leads to transcriptional reprogramming causing cancer cell development and altered immune response. Our finding shows how HCV infection in liver organoids mimics HCV infection and patient pathogenesis. These results reveal that HCV infection in liver organoids contributes to liver disease progression.

2.
Viruses ; 15(11)2023 Oct 28.
Article in English | MEDLINE | ID: mdl-38005849

ABSTRACT

Despite remarkable progress, a cure for HIV-1 infection remains elusive. Rebound competent latent and transcriptionally active reservoir cells persevere despite antiretroviral therapy and rekindle infection due to inefficient proviral silencing. We propose a novel "block-lock-stop" approach, entailing long term durable silencing of viral expression towards an irreversible transcriptionally inactive latent provirus to achieve long term antiretroviral free control of the virus. A graded transformation of remnant HIV-1 in PLWH from persistent into silent to permanently defective proviruses is proposed, emulating and accelerating the natural path that human endogenous retroviruses (HERVs) take over millions of years. This hypothesis was based on research into delineating the mechanisms of HIV-1 latency, lessons from latency reversing agents and advances of Tat inhibitors, as well as expertise in the biology of HERVs. Insights from elite controllers and the availability of advanced genome engineering technologies for the direct excision of remnant virus set the stage for a rapid path to an HIV-1 cure.


Subject(s)
Endogenous Retroviruses , HIV Infections , HIV Seropositivity , HIV-1 , Humans , HIV-1/genetics , Virus Latency , Proviruses/genetics , HIV Seropositivity/genetics , CD4-Positive T-Lymphocytes
3.
Sci Total Environ ; 770: 144745, 2021 May 20.
Article in English | MEDLINE | ID: mdl-33736363

ABSTRACT

Diluted bitumen, also known as dilbit, is transported by rail and pipeline across Canada and the United States. Due to the fewer number of studies characterizing the toxicity of dilbit, a dilbit spill poses an unknown risk to freshwater aquatic ecosystems. In the following study, we compared the impact of early-life exposure to conventional and unconventional crude oils on the optomotor behavior, reproductive success, and transgenerational differences in gene expression in zebrafish and their progeny. For exposures, water accommodated fractions (WAFs) of crude oil were generated using a 1:1000 oil to water ratio for 3 different crudes; mixed sweet blend (MSB), medium sour composite (MSC) and dilbit. All three oils generated unique volatile organic compound (VOC) and polycyclic aromatic compound (PAC) profiles. Of the WAFs tested, only dilbit decreased the eye size of 2 dpf larvae, and only MSB exposed larvae had an altered behavioral response to a visual simulation of a predator. Early-life exposure to crude oil had no lasting impact on reproductive success of adult fish; however, each oil had unique impacts on the basal gene expression of the somatically exposed offspring. In this study, the biological effects differed between each of the oils tested, which implied chemical composition plays a critical role in determining the sublethal toxicity of conventional and unconventional crude oils in freshwater ecosystems.


Subject(s)
Petroleum Pollution , Petroleum , Polycyclic Aromatic Hydrocarbons , Water Pollutants, Chemical , Animals , Canada , Ecosystem , Genetic Markers , Petroleum/analysis , Petroleum/toxicity , Petroleum Pollution/adverse effects , Water Pollutants, Chemical/toxicity , Zebrafish
4.
Ecotoxicol Environ Saf ; 205: 111289, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-32949839

ABSTRACT

The Deepwater Horizon oil spill released 3.19 million barrels of crude oil into the Gulf of Mexico, making it the largest oil spill in U.S. history. Weathering and the application of dispersants can alter the solubility of compounds within crude oil, thus modifying the acute toxicity of the crude oil to aquatic life. The primary aim of our study was to determine the lasting impact of early-life stage sheepshead minnow (Cyprinodon variegatus variegatus) exposure to weathered, unweathered and dispersed crude oil on prey capture, male aggression, novel object interaction and global DNA methylation. Embryos were exposed from 1 to 10 dpf to water accommodations of crude oil and were raised to adulthood in artificial seawater. Our results suggest exposure to crude oil did not result in lasting impairment of complex behavioral responses of male sheepshead minnow. Exposure to dispersed weathered oil, however, decreased border dwelling in response to a novel object (i.e. decreased anxiety). Principal component analysis revealed that exposure to weathered oil had no overarching effect, but that unweathered crude oil increased variability in exploratory behaviors but decreased variability in anxiety-associated behaviors. Further work is needed to understand the effects of oil exposure on fish behavior and the potential ecological impact of subtle behavioral changes in fishes.


Subject(s)
Behavior, Animal/drug effects , Killifishes/physiology , Larva/drug effects , Petroleum Pollution/adverse effects , Petroleum/toxicity , Water Pollutants, Chemical/toxicity , Animals , DNA Methylation/drug effects , Ecology , Gulf of Mexico , Killifishes/genetics , Larva/genetics , Larva/physiology , Male , Seawater/chemistry , Weather
5.
Transcription ; 11(2): 66-82, 2020 04.
Article in English | MEDLINE | ID: mdl-32401151

ABSTRACT

The production of mRNA is a dynamic process that is highly regulated by reversible post-translational modifications of the C-terminal domain (CTD) of RNA polymerase II. The CTD is a highly repetitive domain consisting mostly of the consensus heptad sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Phosphorylation of serine residues within this repeat sequence is well studied, but modifications of all residues have been described. Here, we focus on integrating newly identified and lesser-studied CTD post-translational modifications into the existing framework. We also review the growing body of work demonstrating crosstalk between different CTD modifications and the functional consequences of such crosstalk on the dynamics of transcriptional regulation.


Subject(s)
RNA Polymerase II/metabolism , Protein Processing, Post-Translational/genetics , RNA Polymerase II/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Transcription, Genetic/genetics
6.
Sci Total Environ ; 693: 133611, 2019 Nov 25.
Article in English | MEDLINE | ID: mdl-31634996

ABSTRACT

Exposure to oil sands process-affected water (OSPW), a by-product of Canadian oil sands mining operations, can cause both acute and chronic adverse effects in aquatic life. Ozonation effectively degrades naphthenic acids in OSPW, mitigating some of the toxicological effects of exposure. In this study we examined the effect of developmental exposure to raw and ozonated OSPW had on the breeding success, prey capture, and alarm cue response in fish months/years after exposure and the transgenerational effect exposure had on gene expression, global DNA methylation, and larval basal activity. Exposure to raw and ozonated OSPW had no effect on breeding success, and global DNA methylation. Exposure altered the expression of vtg and nkx2.5 in the unexposed F1 generation. Exposure to both raw and ozonated OSPW had a transgenerational impact on larval activity levels, anxiety behaviors, and maximum swim speed compared to the control population. Prey capture success was unaffected, however, the variability in the behavioral responses to the introduction of prey was decreased. Fish developmentally exposed to either treatment were less active before exposure and did not have an anxiety response to the alarm cue hypoxanthine-3-n-oxide. Though ozonation was able to mitigate some of the effects of OSPW exposure, further studies are needed to understand the transgenerational effects and the implications of exposure on complex fish behaviors.


Subject(s)
Oil and Gas Fields , Toxicity Tests , Water Pollutants, Chemical/toxicity , Animals , Biodegradation, Environmental , Canada , Carboxylic Acids , Invertebrates , Larva , Mining , Ozone , Zebrafish
7.
Sci Total Environ ; 647: 1148-1157, 2019 Jan 10.
Article in English | MEDLINE | ID: mdl-30180323

ABSTRACT

The Deepwater Horizon (DWH) oil spill was the biggest in US history and released 3.19 million barrels of light crude oil into the Gulf of Mexico. In this study, we compared the toxicity of water accommodated fractions (WAFs) of naturally weathered crude oils, source oil, and source oil with dispersant mixtures and their effects on developing sheepshead minnow and zebrafish. Although a freshwater fish, zebrafish has been used as a model for marine oil spills owing to the molecular and genetic tools available and their amenability to lab care. Our study not only aimed to determine the effect of crude oil on early life stages of these two fish species, but also aimed to determine whether dissolved crude oil constituents were similar in fresh and saltwater, and if freshwater fish might be a suitable model to study marine spills. Weathering and dispersant had similar effects on WAF composition in both fresh and saltwater, except that the saltwater source oil + dispersant WAF had markedly higher PAH levels than the freshwater equivalent. WAF exposure differentially affected survival, as the LC50 values in %WAF for the zebrafish and sheepshead minnow exposures were 44.9% WAF (95% confidence interval (C.I.) 42.1-47.9) and 16.8% WAF (95% C.I. 13.7-20.5); respectively. Exposure increased heart rate of zebrafish embryos, whereas in sheepshead, source oil exposure had the opposite effect. WAF exposure altered mRNA expression of biotransformation makers, vitellogenin and neurodevelopment genes in both species. Muscle deformations were only found in oil-exposed zebrafish. This is one of the most comprehensive studies to date on crude oil toxicity, and highlights the species-specific differences in cardiotoxicity, estrogenic effects, biotransformation enzyme induction and potential neurotoxicity of crude oil exposure.


Subject(s)
Fishes/physiology , Petroleum/toxicity , Surface-Active Agents/toxicity , Water Pollutants, Chemical/toxicity , Animals , Fresh Water/chemistry , Gulf of Mexico , Petroleum/analysis , Petroleum Pollution , Seawater/chemistry , Surface-Active Agents/analysis , Water Pollutants, Chemical/analysis
8.
Neuroscience ; 398: 55-63, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30529693

ABSTRACT

Sleep disturbances are a common early symptom of neurodegenerative diseases, including Alzheimer's disease (AD) and other age-related dementias, and emerging evidence suggests that poor sleep may be an important contributor to development of amyloid pathology. Of the causes of sleep disturbances, it is estimated that 10-20% of adults in the United States have sleep-disordered breathing (SDB) disorder, with obstructive sleep apnea accounting for the majority of the SBD cases. The clinical and epidemiological data clearly support a link between sleep apnea and AD; yet, almost no experimental research is available exploring the mechanisms associated with this correlative link. Therefore, we exposed an AD-relevant mouse model (APP/PS1 KI) to chronic intermittent hypoxia (IH) (an experimental model of sleep apnea) to begin to describe one of the potential mechanisms by which SDB could increase the risk of dementia. Previous studies have found that astrogliosis is a contributor to neuropathology in models of chronic IH and AD; therefore, we hypothesized that a reactive astrocyte response might be a contributing mechanism in the neuroinflammation associated with sleep apnea. To test this hypothesis, 10-11-month-old wild-type (WT) and APP/PS1 KI mice were exposed to 10 hours of IH, daily for four weeks. At the end of four weeks brains were analyzed from amyloid burden and astrogliosis. No effect was found for chronic IH exposure on amyloid-beta levels or plaque load in the APP/PS1 KI mice. A significant increase in GFAP staining was found in the APP/PS1 KI mice following chronic IH exposure, but not in the WT mice. Profiling of genes associated with different phenotypes of astrocyte activation identified GFAP, CXCL10, and Ggta1 as significant responses activated in the APP/PS1 KI mice exposed to chronic IH.


Subject(s)
Alzheimer Disease/physiopathology , Astrocytes/physiology , Brain/physiopathology , Gliosis/physiopathology , Hypoxia/physiopathology , Sleep Apnea Syndromes/physiopathology , Alzheimer Disease/pathology , Animals , Astrocytes/pathology , Brain/pathology , Disease Models, Animal , Female , Gene Expression Regulation , Gliosis/pathology , Hypoxia/pathology , Male , Mice, Inbred C57BL , Mice, Transgenic , Plaque, Amyloid/pathology , Plaque, Amyloid/physiopathology , Random Allocation , Sleep Apnea Syndromes/pathology
9.
Environ Pollut ; 241: 959-968, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30029330

ABSTRACT

With the ever-increasing amounts of oil sands process-affected water (OSPW) accumulating from Canada's oil sands operations, its eventual release must be considered. As OSPW has been found to be both acutely and chronically toxic to aquatic organisms, remediation processes must be developed to lower its toxicity. Ozone treatment is currently being studied as a tool to facilitate the removal of organic constituents associated with toxicity. Biomarkers (e.g. gene expression) are commonly used when studying the effects of environmental contaminants, however, they are not always indicative of adverse effects at the whole organism level. In this study, we assessed the effects of OSPW exposure on developing zebrafish by linking gene expression to relevant cellular and whole organism level endpoints. We also investigated whether or not ozone treatment decreased biomarkers and any associated toxicity observed from OSPW exposure. The concentrations of classical naphthenic acids in the raw and ozonated OSPW used in this study were 16.9 mg/L and 0.6 mg/L, respectively. Ozone treatment reduced the total amount of naphthenic acids (NAs) in the OSPW sample by 92%. We found that exposure to both raw and ozonated OSPW had no effect on the survival of zebrafish embryos. The expression levels of biotransformation genes CYP1A and CYP1B were induced by raw OSPW exposure, with CYP1B being more highly expressed than CYP1A. In contrast, ozonated OSPW exposure did not increase the expression of CYP1A and only slightly induced CYP1B. A decrease in cardiac development and function genes (NKX2.5 and APT2a2a) was not associates with large changes in heart rate, arrhythmia or heart size. We did not find any indications of craniofacial abnormalities or of increased occurrence of apoptotic cells. Overall, our study found that OSPW was not overtly toxic to zebrafish embryos.


Subject(s)
Ozone/chemistry , Water Pollutants, Chemical/toxicity , Zebrafish/physiology , Animals , Biodegradation, Environmental , Canada , Carboxylic Acids , Gene Expression/drug effects , Oil and Gas Fields , Zebrafish/anatomy & histology , Zebrafish/metabolism
10.
J Virol ; 92(19)2018 10 01.
Article in English | MEDLINE | ID: mdl-30021895

ABSTRACT

Epstein-Barr virus (EBV) ZEBRA protein activates the EBV lytic cycle. Cellular AP-1 proteins with alanine-to-serine [AP-1(A/S)] substitutions homologous to ZEBRA(S186) assume some functions of EBV ZEBRA. These AP-1(A/S) mutants bind methylated EBV DNA and activate expression of some EBV genes. Here, we compare expression of 67 viral genes induced by ZEBRA versus expression induced by AP-1(A/S) proteins. AP-1(A/S) activated 24 genes to high levels and 15 genes to intermediate levels; activation of 28 genes by AP-1(A/S) was severely impaired. We show that AP-1(A/S) proteins are defective at stimulating viral lytic DNA replication. The impairment of expression of many late genes compared to that of ZEBRA is likely due to the inability of AP-1(A/S) proteins to promote viral DNA replication. However, even in the absence of detectable viral DNA replication, AP-1(A/S) proteins stimulated expression of a subgroup of late genes that encode viral structural proteins and immune modulators. In response to ZEBRA, expression of this subgroup of late genes was inhibited by phosphonoacetic acid (PAA), which is a potent viral replication inhibitor. However, when the lytic cycle was activated by AP-1(A/S), PAA did not reduce expression of this subgroup of late genes. We also provide genetic evidence, using the BMRF1 knockout bacmid, that these genes are true late genes in response to ZEBRA. AP-1(A/S) binds to the promoter region of at least one of these late genes, BDLF3, encoding an immune modulator.IMPORTANCE Mutant c-Jun and c-Fos proteins selectively activate expression of EBV lytic genes, including a subgroup of viral late genes, in the absence of viral DNA replication. These findings indicate that newly synthesized viral DNA is not invariably required for viral late gene expression. While viral DNA replication may be obligatory for late gene expression driven by viral transcription factors, it does not limit the ability of cellular transcription factors to activate expression of some viral late genes. Our results show that expression of all late genes may not be strictly dependent on viral lytic DNA replication. The c-Fos A151S mutation has been identified in a human cancer. c-Fos A151S in combination with wild-type c-Jun activates the EBV lytic cycle. Our data provide proof of principle that mutant cellular transcription factors could cause aberrant regulation of viral lytic cycle gene expression and play important roles in EBV-associated diseases.


Subject(s)
Antigens, Viral/genetics , DNA, Viral/genetics , Herpesvirus 4, Human/genetics , Host-Pathogen Interactions , Membrane Glycoproteins/genetics , Trans-Activators/genetics , Transcription Factor AP-1/genetics , Viral Proteins/genetics , Amino Acid Substitution , Antigens, Viral/immunology , Antiviral Agents/pharmacology , Binding Sites , Cell Line, Tumor , DNA Methylation/drug effects , DNA, Viral/immunology , Gene Expression Regulation , HEK293 Cells , Herpesvirus 4, Human/drug effects , Herpesvirus 4, Human/immunology , Humans , Lymphocytes/immunology , Lymphocytes/virology , Membrane Glycoproteins/immunology , Mutation , Phosphonoacetic Acid/pharmacology , Promoter Regions, Genetic , Protein Binding , Signal Transduction , Trans-Activators/immunology , Transcription Factor AP-1/immunology , Viral Proteins/immunology , Virus Replication/drug effects
11.
J Neurotrauma ; 35(20): 2435-2447, 2018 10 15.
Article in English | MEDLINE | ID: mdl-29808778

ABSTRACT

Metabolic uncoupling has been well-characterized during the first minutes-to-days after a traumatic brain injury (TBI), yet mitochondrial bioenergetics during the weeks-to-months after a brain injury is poorly defined, particularly after a mild TBI. We hypothesized that a closed head injury (CHI) would be associated with deficits in mitochondrial bioenergetics at one month after the injury. A significant decrease in state-III (adenosine triphosphate production) and state-V (complex-I) driven mitochondrial respiration was found at one month post-injury in adult C57Bl/6J mice. Isolation of synaptic mitochondria demonstrated that the deficit in state-III and state-V was primarily neuronal. Injured mice had a temporally consistent deficit in memory recall at one month post-injury. Using proton magnetic resonance spectroscopy (1H MRS) at 7-Tesla, we found significant decreases in phosphocreatine, N-Acetylaspartic acid, and total choline. We also found regional variations in cerebral blood flow, including both hypo- and hyperperfusion, as measured by a pseudocontinuous arterial spin labeling MR sequence. Our results highlight a chronic deficit in mitochondrial bioenergetics associated with a CHI that may lead toward a novel approach for neurorestoration after a mild TBI. MRS provides a potential biomarker for assessing the efficacy of candidate treatments targeted at improving mitochondrial bioenergetics.


Subject(s)
Brain Concussion/metabolism , Brain Concussion/pathology , Mitochondria/metabolism , Mitochondria/pathology , Animals , Brain/metabolism , Brain/pathology , Energy Metabolism/physiology , Mice , Mice, Inbred C57BL
12.
Chemosphere ; 206: 405-413, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29758497

ABSTRACT

Due to the increasing volume of oil sands process-affect water (OSPW) and its toxicity to aquatic organisms, it is important to fully understand its effects and study remediation processes that will enable its release to the environment. Ozone treatment is currently being considered as a tool to expedite remediation, as it is known to degrade toxic organic compounds present in OSPW. In this study, we aimed to measure the effects of OSPW exposure on the growth, development and recovery of zebrafish (Danio rerio) embryos. We also used ozone-treated OSPW to determine whether ozonation negated any effects of raw OSPW exposure. As biomarkers of exposure, we assessed the expression of genes involved in neurodevelopment (ngn1, neuroD), estrogenicity (vtg), oxidative stress (sod1), and biotransformation (cyp1a, cyp1b). Our study found that exposure to both raw and ozonated OSPW did not impair growth of zebrafish embryos, however, otoliths of exposed embryos were smaller than those of control embryos. The expression levels of both cyp1a and cyp1b were induced by raw OSPW exposure. However, after the exposure period, expression levels of these genes returned to control levels within two days of residence in clean water. We found no changes in the expression levels of ngn1, neuroD and vtg genes with exposure to treated or untreated OSPW. Overall, our study found that raw OSPW exposure did not have many negative effects on zebrafish embryos and embryos appeared to recover relatively quickly after exposure ended. Furthermore, ozone treatment decreased the induction of cyp1a and cyp1b.


Subject(s)
Oil and Gas Fields/chemistry , Ozone/chemistry , Water Pollutants, Chemical/toxicity , Zebrafish/embryology , Animals
13.
Clin J Pain ; 34(2): 168-177, 2018 02.
Article in English | MEDLINE | ID: mdl-28542026

ABSTRACT

OBJECTIVES: The study aim was to determine how peripheral trigeminal nerve injury affects mitochondrial respiration and to test efficacy of combined treatment with 2 Federal Drug Administration approved drugs with potential for improving mitochondrial bioenergetics, pain and anxiety-related behaviors in a chronic orofacial neuropathic pain mouse model. METHODS: Efficacy of (R)-(+)-4-amino-3-isoxazolidinone (D-cycloserine, DCS), an N-Methyl-D-aspartate antagonist/agonist, and Pioglitazone (PIO), a selective agonist of nuclear receptor peroxisome proliferator-activated receptor gamma was investigate in the trigeminal inflammatory compression (TIC) neuropathic nerve injury mouse model. Combined low doses of these drugs (80 mg/kg DCS and 100 mg/kg PIO) were given as a single bolus or daily for 7 days post-TIC to test ability to attenuate neuropathic nociceptive and associated cognitive dependent anxiety behaviors. In addition, beneficial effects of the DCS/PIO drug combination were explored ex vivo in isolated cortex/brainstem mitochondria at 28 weeks post-TIC. RESULTS: The DCS/PIO combination not only attenuated orofacial neuropathic pain and anxiety-related behaviors associated with trigeminal nerve injury, but it also improved mitochondrial bioenergetics. DISCUSSION: The DCS/PIO combination uncoupled mitochondrial respiration in the TIC model to improve cortical mitochondrial dysfunction, as well as reduced nociceptive and anxiety behaviors present in mice with centralized chronic neuropathic nerve injury. Combining these drugs could be a beneficial treatment for patients with depression, anxiety, or other psychological conditions due to their chronic pain status.


Subject(s)
Analgesics/pharmacology , Chronic Pain/drug therapy , Cycloserine/pharmacology , Facial Pain/drug therapy , Neuralgia/drug therapy , Pioglitazone/pharmacology , Trigeminal Nerve Injuries/drug therapy , Animals , Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Anxiety/metabolism , Brain/drug effects , Brain/metabolism , Chronic Pain/metabolism , Chronic Pain/psychology , Cognition/drug effects , Disease Models, Animal , Drug Therapy, Combination , Facial Pain/metabolism , Facial Pain/psychology , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Hyperalgesia/psychology , Male , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/metabolism , Neuralgia/metabolism , Neuralgia/psychology , Random Allocation , Trigeminal Nerve Injuries/metabolism , Trigeminal Nerve Injuries/psychology
14.
Neurobiol Aging ; 56: 78-86, 2017 08.
Article in English | MEDLINE | ID: mdl-28500878

ABSTRACT

Tauopathies, the most common of which is Alzheimer's disease (AD), constitute the most crippling neurodegenerative threat to our aging population. Tauopathic patients have significant cognitive decline accompanied by irreversible and severe brain atrophy, and it is thought that neuronal dysfunction begins years before diagnosis. Our current understanding of tauopathies has yielded promising therapeutic interventions but have all failed in clinical trials. This is partly due to the inability to identify and intervene in an effective therapeutic window early in the disease process. A major challenge that contributes to the definition of an early therapeutic window is limited technologies. To address these challenges, we modified and adapted a manganese-enhanced magnetic resonance imaging (MEMRI) approach to provide sensitive and quantitative power to detect changes in broad neuronal function in aging mice. Considering that tau tangle burden correlates well with cognitive impairment in Alzheimer's patients, we performed our MEMRI approach in a time course of aging mice and an accelerated mouse model of tauopathy. We measured significant changes in broad neuronal function as a consequence of age, and in transgenic mice, before the deposition of bona fide tangles. This MEMRI approach represents the first diagnostic measure of neuronal dysfunction in mice. Successful translation of this technology in the clinic could serve as a sensitive diagnostic tool for the definition of effective therapeutic windows.


Subject(s)
Aging/pathology , Aging/physiology , Magnetic Resonance Imaging/methods , Neurodegenerative Diseases/diagnostic imaging , Neurodegenerative Diseases/physiopathology , Neuroimaging/methods , Neurons/pathology , Neurons/physiology , Tauopathies/diagnostic imaging , Tauopathies/physiopathology , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Animals , Disease Models, Animal , Early Diagnosis , Humans , Manganese , Mice, Transgenic , Neurodegenerative Diseases/pathology , Sensitivity and Specificity , Tauopathies/pathology
15.
Clin J Pain ; 33(12): 1071-1080, 2017 12.
Article in English | MEDLINE | ID: mdl-28514232

ABSTRACT

OBJECTIVES: The aim of this study is to investigate the role of peroxisome proliferator-activated receptor-gamma isoform (PPARγ), in trigeminal neuropathic pain utilizing a novel mouse trigeminal inflammatory compression (TIC) injury model. RESULTS: The study determined that the PPARγ nuclear receptor plays a significant role in trigeminal nociception transmission, evidenced by: 1) Intense PPARγ immunoreactivity is expressed 3 weeks after TIC nerve injury in the spinal trigeminal caudalis, the termination site of trigeminal nociceptive nerve fibers. 2) Systemic administration of a PPARγ agonist, pioglitazone (PIO), attenuates whisker pad mechanical allodynia at doses of 300 mg/kg i.p. and 600 mg/kg p.o. 3) Administration of a PPARγ antagonist, GW9662 (30 mg/kg i.p.), prior to providing the optimal dose of PIO (300 mg/kg i.p.) blocked the analgesic effect of PIO. DISCUSSION: This is the first study localizing PPARγ immunoreactivity throughout the brainstem trigeminal sensory spinal nucleus (spV) and its increase three weeks after TIC nerve injury. This is also the first study to demonstrate that activation of PPARγ attenuates trigeminal hypersensitivity in the mouse TIC nerve injury model. The findings presented here suggest the possibility of utilizing the FDA approved diabetic treatment drug, PIO, as a new therapeutic that targets PPARγ for treatment of patients suffering from orofacial neuropathic pain.


Subject(s)
Analgesics, Non-Narcotic/pharmacology , Facial Pain/drug therapy , Neuralgia/drug therapy , PPAR gamma/agonists , Thiazolidinediones/pharmacology , Trigeminal Nerve Injuries/drug therapy , Anilides/pharmacology , Animals , Disease Models, Animal , Facial Pain/pathology , Facial Pain/physiopathology , Hyperalgesia/pathology , Hyperalgesia/physiopathology , Male , Mice, Inbred C57BL , Neuralgia/pathology , Neuralgia/physiopathology , PPAR alpha/agonists , PPAR alpha/metabolism , PPAR delta/agonists , PPAR delta/metabolism , PPAR gamma/antagonists & inhibitors , PPAR gamma/metabolism , Pioglitazone , Random Allocation , Trigeminal Nerve Injuries/pathology , Trigeminal Nerve Injuries/physiopathology , Trigeminal Nuclei/drug effects , Trigeminal Nuclei/metabolism , Trigeminal Nuclei/pathology , Vibrissae
16.
Behav Anal Pract ; 9(3): 253-6, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27622130

ABSTRACT

The effects of differential reinforcement of other behaviour (DRO) were investigated for the treatment of severe self-injurious nail biting in an individual diagnosed with autism. A functional behaviour assessment (FBA) identified that the behaviour was maintained by automatic reinforcement. Following the implementation of the DRO procedure and access to reinforcing stimuli that were believed to provide similar sensory feedback to that of the self-injurious nail biting, the results indicate that the nail biting was successfully reduced and maintained at near zero levels.

17.
mBio ; 7(2): e00113, 2016 Mar 01.
Article in English | MEDLINE | ID: mdl-26933051

ABSTRACT

UNLABELLED: Reactivation of Epstein-Barr virus (EBV) from latency into the lytic phase of its life cycle allows the virus to spread among cells and between hosts. Valproic acid (VPA) inhibits initiation of the lytic cycle in EBV-infected B lymphoma cells. While VPA blocks viral lytic gene expression, it induces expression of many cellular genes, because it is a histone deacetylase (HDAC) inhibitor. Here we show, using derivatives of VPA, that blockade of EBV reactivation is separable from HDAC inhibition. Valpromide (VPM), an amide derivative of valproic acid that is not an HDAC inhibitor, prevented expression of two EBV genes, BZLF1 and BRLF1, that mediate lytic reactivation. VPM also inhibited expression of a viral late gene, but not early genes, when BZLF1 was exogenously expressed. Unlike VPA, VPM did not activate lytic expression of Kaposi's sarcoma-associated herpesvirus. Expression of cellular immediate-early genes, such as FOS and EGR1, is kinetically upstream of the EBV lytic cycle. VPM did not activate expression of these cellular immediate-early genes but decreased their level of expression when induced by butyrate, an HDAC inhibitor. VPM did not alter expression of several other cellular immediate-early genes, including STAT3, which were induced by the HDAC inhibitors in cells refractory to lytic induction. Therefore, VPM selectively inhibits both viral and cellular gene expression. VPA and VPM represent a new class of antiviral agents. The mechanism by which VPA and VPM block EBV reactivation may be related to their anticonvulsant activity. IMPORTANCE: Epstein-Barr virus, (EBV), a human tumor virus, establishes a life-long latent infection. Reactivation of EBV into the lytic phase of its life cycle allows the virus to spread. Previously, we showed that EBV reactivation was blocked by valproic acid (VPA), an inhibitor of cellular histone deacetylases (HDACs). VPA alters the expression of thousands of cellular genes. In this study, we demonstrate that valpromide (VPM), an amide derivative of valproic acid that is not an HDAC inhibitor, prevented initiation of the EBV lytic cycle. VPA induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV), but VPM did not. Unlike VPA, VPM did not activate cellular immediate-early gene expression. VPM is a new type of antiviral agent. VPM will be useful in probing the mechanism of EBV lytic reactivation and may have therapeutic application.


Subject(s)
Antiviral Agents/pharmacology , Herpesvirus 4, Human/drug effects , Herpesvirus 4, Human/physiology , Valproic Acid/analogs & derivatives , Virus Activation/drug effects , B-Lymphocytes/drug effects , B-Lymphocytes/virology , Cell Line , Gene Expression/drug effects , Humans , Immediate-Early Proteins/antagonists & inhibitors , Trans-Activators/antagonists & inhibitors , Valproic Acid/pharmacology
18.
J Neurosci ; 36(3): 1001-7, 2016 Jan 20.
Article in English | MEDLINE | ID: mdl-26791227

ABSTRACT

One of the most common symptoms of Alzheimer's disease (AD) and related tauopathies is memory loss. The exact mechanisms leading to memory loss in tauopathies are not yet known; however, decreased translation due to ribosomal dysfunction has been implicated as a part of this process. Here we use a proteomics approach that incorporates subcellular fractionation and coimmunoprecipitation of tau from human AD and non-demented control brains to identify novel interactions between tau and the endoplasmic reticulum (ER). We show that ribosomes associate more closely with tau in AD than with tau in control brains, and that this abnormal association leads to a decrease in RNA translation. The aberrant tau-ribosome association also impaired synthesis of the synaptic protein PSD-95, suggesting that this phenomenon contributes to synaptic dysfunction. These findings provide novel information about tau-protein interactions in human brains, and they describe, for the first time, a dysfunctional consequence of tau-ribosome associations that directly alters protein synthesis. Significance statement: Despite the identification of abnormal tau-ribosomal interactions in tauopathies >25 years ago, the consequences of this association remained elusive until now. Here, we show that pathological tau associates closely with ribosomes in AD brains, and that this interaction impairs protein synthesis. The overall result is a stark reduction of nascent proteins, including those that participate in synaptic plasticity, which is crucial for learning and memory. These data mechanistically link a common pathologic sign, such as the appearance of pathological tau inside brain cells, with cognitive impairments evident in virtually all tauopathies.


Subject(s)
Neurons/metabolism , Neurons/pathology , Protein Biosynthesis/physiology , Ribosomes/physiology , tau Proteins/biosynthesis , Aged, 80 and over , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Brain/metabolism , Brain/pathology , Cells, Cultured , Female , Humans , Male , Microsomes/metabolism , Microsomes/pathology , Tauopathies/metabolism , Tauopathies/pathology
19.
J Alzheimers Dis ; 48(3): 687-702, 2015.
Article in English | MEDLINE | ID: mdl-26402096

ABSTRACT

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is pathologically characterized by the formation of extracellular amyloid plaques and intraneuronal tau tangles. We recently identified that tau associates with proteins known to participate in endoplasmic reticulum (ER)-associated degradation (ERAD); consequently, ERAD becomes dysfunctional and causes neurotoxicity. We hypothesized that tau associates with other ER proteins, and that this association could also lead to cellular dysfunction in AD. Portions of human AD and non-demented age matched control brains were fractionated to obtain microsomes, from which tau was co-immunoprecipitated. Samples from both conditions containing tau and its associated proteins were analyzed by mass spectrometry. In total, we identified 91 ER proteins that co-immunoprecipitated with tau; 15.4% were common between AD and control brains, and 42.9% only in the AD samples. The remainder, 41.8% of the proteins, was only seen in the control brain samples. We identified a variety of previously unreported interactions between tau and ER proteins. These proteins participate in over sixteen functional categories, the most abundant being involved in RNA translation. We then determined that association of tau with these ER proteins was different between the AD and control samples. We found that tau associated equally with the ribosomal protein L28 but more robustly with the ribosomal protein P0. These data suggest that the differential association between tau and ER proteins in disease could reveal the pathogenic processes by which tau induces cellular dysfunction.


Subject(s)
Alzheimer Disease/metabolism , Endoplasmic Reticulum/metabolism , Temporal Lobe/metabolism , tau Proteins/metabolism , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Blotting, Western , Endoplasmic Reticulum/pathology , Female , Fluorescent Antibody Technique , Humans , Immunoprecipitation , Male , Mass Spectrometry , Microscopy, Confocal , Microsomes/metabolism , Microsomes/pathology , Proteome , Temporal Lobe/pathology
20.
Mol Brain ; 5: 44, 2012 Dec 28.
Article in English | MEDLINE | ID: mdl-23270529

ABSTRACT

BACKGROUND: Trigeminal neuropathic pain attacks can be excruciating for patients, even after being lightly touched. Although there are rodent trigeminal nerve research models to study orofacial pain, few models have been applied to studies in mice. A mouse trigeminal inflammatory compression (TIC) model is introduced here which successfully and reliably promotes vibrissal whisker pad hypersensitivity. RESULTS: The chronic orofacial neuropathic pain model is induced after surgical placement of chromic gut suture in the infraorbital nerve fissure in the maxillary bone. Slight compression and chemical effects of the chromic gut suture on the portion of the infraorbital nerve contacted cause mild nerve trauma. Nerve edema is observed in the contacting infraorbital nerve bundle as well as macrophage infiltration in the trigeminal ganglia. Centrally in the spinal trigeminal nucleus, increased immunoreactivity for an activated microglial marker is evident (OX42, postoperative day 70). Mechanical thresholds of the affected whisker pad are significantly decreased on day 3 after chromic gut suture placement, persisting at least 10 weeks. The mechanical allodynia is reversed by suppression of microglial activation. Cold allodynia was detected at 4 weeks. CONCLUSIONS: A simple, effective, and reproducible chronic mouse model mimicking clinical orofacial neuropathic pain (Type 2) is induced by placing chromic gut suture between the infraorbital nerve and the maxillary bone. The method produces mild inflammatory compression with significant continuous mechanical allodynia persisting at least 10 weeks and cold allodynia measureable at 4 weeks.


Subject(s)
Facial Pain/pathology , Inflammation/pathology , Nerve Compression Syndromes/pathology , Neuralgia/pathology , Orbit/innervation , Orbit/pathology , Trigeminal Nerve/pathology , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Facial Pain/complications , Hyperalgesia/complications , Hyperalgesia/pathology , Imidazoles/pharmacology , Inflammation/complications , Male , Mice , Mice, Inbred C57BL , Microglia/drug effects , Microglia/pathology , Minocycline/pharmacology , Nerve Compression Syndromes/complications , Neuralgia/complications , Neurons/drug effects , Neurons/pathology , Orbit/drug effects , Purinergic P2X Receptor Antagonists/pharmacology , Pyridines/pharmacology , Tetrazoles/pharmacology , Trigeminal Ganglion/drug effects , Trigeminal Ganglion/pathology , Trigeminal Nerve/drug effects , Trigeminal Neuralgia/complications , Trigeminal Neuralgia/pathology , Trigeminal Nucleus, Spinal/drug effects , Trigeminal Nucleus, Spinal/pathology , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...